| Image | Name | Description | Cores | Cases | price/slide | ||
|---|---|---|---|---|---|---|---|
| Unstained | H&E | ||||||
|
DLV581 | Primary liver cancer (stage I) with liver tissue array (2010 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 29 cases/58 cores | 58 | 29 | 306.00 | 306.00 | |
|
|
DLV631 | Liver cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 63 cases/63 cores | 63 | 63 | 270.00 | 270.00 | |
|
|
DLV631a | Liver cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 63 cases/63 cores, replacing DLV631 | 63 | 63 | 270.00 | 270.00 | |
|
|
DES1921 | Middle-advanced stage esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores | 192 | 96 | 270.00 | 270.00 | |
|
|
DES1922 | Esophagus squamous cell carcinoma with matched adjacent nomal esophagus tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores | 192 | 96 | 395.00 | 395.00 | |
|
|
DES02012 | Esophagus cancer with adjacent normal esophagus tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores | 72 | 72 | 168.00 | 168.00 | |
|
|
DES02012b | Esophagus cancer with adjacent normal esophagus tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores | 72 | 72 | 168.00 | 168.00 | |
|
|
DES8011a | Esophagus cancer and normal tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores | 80 | 40 | 270.00 | 270.00 | |
|
|
DES8012 | Middle-advanced stage esophagus cancer tissue array with metastasis tissue，including pathology grade, TNM and clinical stage, 80 cases/80 cores | 80 | 80 | 270.00 | 270.00 | |
|
|
DGA461 | Gallbladder cancer with matched cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 20 cases/46 cores | 46 | 20 | 168.00 | 168.00 | |
|
|
DGA751 | Gallbladder adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 75 cases/75 cores | 75 | 75 | 270.00 | 270.00 | |
|
|
DGA802 | Extrahepatic bile duct cancer and intrahepatic cholangiocarcinoma tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores | 80 | 80 | 270.00 | 270.00 | |
|
|
DGA2081 | Gallbladder disease spectrum (cholecystic cancer progression) tissue array, including pathology grade, TNM and clinical stage, 104 cases/208 cores | 208 | 104 | 546.00 | 546.00 | |
|
|
DIG803 | Digestive system (colon, rectum, small intestine, esophagus, stomach, liver, pancreas, oral cavity) tumor with most matched adjacent normal or cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 42 cases/80 cores | 80 | 42 | 306.00 | 306.00 | |
|
|
DIG1441a | Digestive system (esophagus, stomach, colon, rectum, liver, pancreas) cancer with matched adjacent normal tissue array, including pathology grade, TNM and clinical stage, 84 cases/144 cores | 144 | 84 | 306.00 | 306.00 | |
| Image | Name | Description | Cores | Cases | price/slide | ||
|---|---|---|---|---|---|---|---|
| Unstained | H&E | ||||||
|
|
DLV581 | Primary liver cancer (stage I) with liver tissue array (2010 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 29 cases/58 cores | 58 | 29 | 306.00 | 306.00 | |
|
|
DLV631 | Liver cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 63 cases/63 cores | 63 | 63 | 270.00 | 270.00 | |
|
|
DLV631a | Liver cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 63 cases/63 cores, replacing DLV631 | 63 | 63 | 270.00 | 270.00 | |
|
|
DES1921 | Middle-advanced stage esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores | 192 | 96 | 270.00 | 270.00 | |
|
|
DES1922 | Esophagus squamous cell carcinoma with matched adjacent nomal esophagus tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores | 192 | 96 | 395.00 | 395.00 | |
|
|
DES02012 | Esophagus cancer with adjacent normal esophagus tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores | 72 | 72 | 168.00 | 168.00 | |
|
|
DES02012b | Esophagus cancer with adjacent normal esophagus tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores | 72 | 72 | 168.00 | 168.00 | |
|
|
DES8011a | Esophagus cancer and normal tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores | 80 | 40 | 270.00 | 270.00 | |
|
|
DES8012 | Middle-advanced stage esophagus cancer tissue array with metastasis tissue，including pathology grade, TNM and clinical stage, 80 cases/80 cores | 80 | 80 | 270.00 | 270.00 | |
|
|
DGA461 | Gallbladder cancer with matched cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 20 cases/46 cores | 46 | 20 | 168.00 | 168.00 | |
|
|
DGA751 | Gallbladder adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 75 cases/75 cores | 75 | 75 | 270.00 | 270.00 | |
|
|
DGA802 | Extrahepatic bile duct cancer and intrahepatic cholangiocarcinoma tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores | 80 | 80 | 270.00 | 270.00 | |
|
|
DGA2081 | Gallbladder disease spectrum (cholecystic cancer progression) tissue array, including pathology grade, TNM and clinical stage, 104 cases/208 cores | 208 | 104 | 546.00 | 546.00 | |
|
|
DIG803 | Digestive system (colon, rectum, small intestine, esophagus, stomach, liver, pancreas, oral cavity) tumor with most matched adjacent normal or cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 42 cases/80 cores | 80 | 42 | 306.00 | 306.00 | |
|
|
DIG1441a | Digestive system (esophagus, stomach, colon, rectum, liver, pancreas) cancer with matched adjacent normal tissue array, including pathology grade, TNM and clinical stage, 84 cases/144 cores | 144 | 84 | 306.00 | 306.00 | |
| Image | Product Number | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type | price/pack (5 slides) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unstained | H&E | |||||||||||
|
|
Ukn203017 | 26 | F | Kidney | Renal clear cell carcinoma | 2 | T3aN0M0 | III | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203016 | 39 | M | Kidney | Renal chromophobe cell carcinoma | 2 | T1aN0M0 | I | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203015 | 34 | F | Kidney | Papillary renal cell carcinoma | 2 | T2aN1M0 | III | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203014 | 72 | M | Kidney | Renal chromophobe cell carcinoma | 2 | T2aN1M0 | II | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203013 | 37 | M | Kidney | Papillary renal cell carcinoma | 1 | T1aN0M0 | I | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203012 | 30 | M | Kidney | Papillary renal cell carcinoma | 1 | T1bN0M0 | I | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203011 | 63 | F | Kidney | Renal clear cell carcinoma | 3 | T3aN0M0 | III | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203010 | 60 | F | Kidney | Renal clear cell carcinoma | 1 | T1bN0M0 | I | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203009 | 61 | F | Kidney | Renal clear cell carcinoma | 1 | T1bN0M0 | I | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203008 | 54 | M | Kidney | Renal clear cell carcinoma | 2 | T1bN0M0 | I | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203007 | 65 | F | Kidney | Renal clear cell carcinoma | 3 | 3aN0M0 | III | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203006 | 70 | M | Kidney | Renal clear cell carcinoma | 1 | T3aN0M0 | III | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203005 | 70 | M | Kidney | Renal clear cell carcinoma | 1 | T3aN0M0 | III | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203004 | 53 | M | Kidney | Renal clear cell carcinoma | 3 | T4N0M0 | IV | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203003 | 76 | M | Kidney | Renal clear cell carcinoma | 3 | T4N0M0 | IV | FFPE |
$95.00
|
$95.00
|
|
| Image | Product Number | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type | price/pack (5 slides) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unstained | H&E | |||||||||||
|
|
Ukn203017 | 26 | F | Kidney | Renal clear cell carcinoma | 2 | T3aN0M0 | III | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203016 | 39 | M | Kidney | Renal chromophobe cell carcinoma | 2 | T1aN0M0 | I | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203015 | 34 | F | Kidney | Papillary renal cell carcinoma | 2 | T2aN1M0 | III | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203014 | 72 | M | Kidney | Renal chromophobe cell carcinoma | 2 | T2aN1M0 | II | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203013 | 37 | M | Kidney | Papillary renal cell carcinoma | 1 | T1aN0M0 | I | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203012 | 30 | M | Kidney | Papillary renal cell carcinoma | 1 | T1bN0M0 | I | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203011 | 63 | F | Kidney | Renal clear cell carcinoma | 3 | T3aN0M0 | III | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203010 | 60 | F | Kidney | Renal clear cell carcinoma | 1 | T1bN0M0 | I | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203009 | 61 | F | Kidney | Renal clear cell carcinoma | 1 | T1bN0M0 | I | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203008 | 54 | M | Kidney | Renal clear cell carcinoma | 2 | T1bN0M0 | I | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203007 | 65 | F | Kidney | Renal clear cell carcinoma | 3 | 3aN0M0 | III | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203006 | 70 | M | Kidney | Renal clear cell carcinoma | 1 | T3aN0M0 | III | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203005 | 70 | M | Kidney | Renal clear cell carcinoma | 1 | T3aN0M0 | III | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203004 | 53 | M | Kidney | Renal clear cell carcinoma | 3 | T4N0M0 | IV | FFPE |
$95.00
|
$95.00
|
|
|
|
Ukn203003 | 76 | M | Kidney | Renal clear cell carcinoma | 3 | T4N0M0 | IV | FFPE |
$95.00
|
$95.00
|
|
